FIELD: chemistry; pharmaceutics.
SUBSTANCE: invention relates to a salt of montelukast with β2 adrenergic agonist, where β2 adrenergic agonist is selected from formoterol and salbutamol. Method for preparing said montelukast salt, a pharmaceutical composition containing said montelukast salt and use of said montelukast salt as a medicinal agent are also provided.
EFFECT: obtaining novel montelukast salts having a synergistic therapeutic effect in treating allergen-caused respiratory tract dysfunctions.
14 cl, 18 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS CONTAINING ANTI-MUSCARINE PREPARATIONS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2379033C2 |
| COMBINATIONS, CONNECTING ANTI-MUSCARINIC PREPARATIONS AND BETA-ADRENERTIC AGONISTS | 2010 |
|
RU2465902C2 |
| COMBINATIONS CONTAINING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | 2005 |
|
RU2404771C2 |
| COMBINATION AND PHARMACEUTICAL PREPARATION FOR TREATMENT OF INFLAMMATORY DISEASES | 2006 |
|
RU2465915C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2568882C2 |
| CRYSTALLINE MICRO PARTICLES OF BETA-AGONIST, COATED WITH FATTY ACID | 2012 |
|
RU2629085C2 |
| COMBINATION OF R,R-GLYCOPYRROLATE AND MONTELUKAST FOR TREATMENT OF RESPIRATORY DISEASES AND BASED ON IT PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2420285C2 |
| NEW DOSE AND FORMULATION | 2009 |
|
RU2608713C2 |
| DRY POWDER COMPOSITIONS REPRESENTED AS PARTICLES WHICH CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATMENT OF OBSTRUCTIVE OR INFLAMMATORY DISEASES OF RESPIRATORY WAYS | 2012 |
|
RU2629333C2 |
| DERIVATIVES OF BENZIMIDAZOLE AS MODULATING AGENTS OF IGE | 1999 |
|
RU2236221C2 |
